Arcus: Excellent Pipeline And Collaborations, Cash Runway

I covered Arcus Biosciences (NYSE: RCUS ) back in August 2023, and I said that the company had Terry Rosen, well-known biotech entrepreneur, as its CEO, major collaborations, a huge load of cash, but little data to justify all that. Since then, the company hasAbout the TPT serviceThanks for reading. At the Total Pharma Tracker, we offer the following:-Our Android app and website features a set of tools for DIY investors, including a work-in-progress software where you can enter any ticker and get extensive ...